학술논문
The ECHELON-2 Trial: Results of a Randomized, Double-Blind, Active-Controlled Phase 3 Study of Brentuximab Vedotin and CHP (A plus CHP) Versus CHOP in the Frontline Treatment of Patients with CD30+Peripheral T-Cell Lymphomas
Document Type
Journal
Author
Horwitz, Steven M.; O'Connor, Owen A.; Pro, Barbara; Illidge, Tim M.; Fanale, Michelle A.; Advani, Ranjana H.; Bartlett, Nancy L.; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana A.; Lennard, Anne; Belada, David; Illes, Arpad; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei R.; Huettmann, Andreas; Savage, Kerry J.; Yuen, Sam; Zinzani, Pier Luigi; Hua, Zhaowei; Little, Meredith; Rao, Shangbang; Woolery, Joseph; Manley, Thomas; Truemper, Lorenz
Source
Subject
Language
English
ISSN
15280020